ADC Therapeutics SA (NYSE:ADCT) Q4 2024 Earnings Call Transcript March 27, 2025
ADC Therapeutics SA beats earnings expectations. Reported EPS is $-0.29, expectations were $-0.35.
Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] I will now turn the call over...
